Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recurrent inflammation that requires lifelong treatments. Probiotic microorganisms appear as an alternative for these patients; however, probiotic characteristics are strain dependent and each probiotic needs to be tested to understand the underlining mechanisms involved in their beneficial properties. Genetic modification of lactic acid bacteria (LAB) was also described as a tool for new IBD treatments.The first part of this review shows different genetically modified LAB (GM-LAB) described for IBD treatment since 2000.Then, the two principally studied strategies are discussed (i) GM-LAB producing antioxidant enzymes and (ii) GM-LAB producing the...
The human gastrointestinal tract (GIT) is highly colonized by bacterial communities, which live in a...
Background: Mucosal delivery of therapeutic proteins using genetically modified strains of lactic ac...
Background: Mucosal delivery of therapeutic proteins using genetically modified strains of lactic ac...
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recur...
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recur...
Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn's disease, are chronic in...
Inflammatory bowel disease (IBD) is a term used to describe a group of intestinal disorders in which...
Inflammatory bowel diseases (IBDs) affect the gastrointestinal tract and are characterized by recurr...
Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Gen...
Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Gen...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally pres...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that have been shown to...
Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Gen...
Inflammatory Bowel Diseases or IBD affect the gastrointestinal tract and are characterized by recurr...
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is a m...
The human gastrointestinal tract (GIT) is highly colonized by bacterial communities, which live in a...
Background: Mucosal delivery of therapeutic proteins using genetically modified strains of lactic ac...
Background: Mucosal delivery of therapeutic proteins using genetically modified strains of lactic ac...
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recur...
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recur...
Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn's disease, are chronic in...
Inflammatory bowel disease (IBD) is a term used to describe a group of intestinal disorders in which...
Inflammatory bowel diseases (IBDs) affect the gastrointestinal tract and are characterized by recurr...
Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Gen...
Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Gen...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally pres...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that have been shown to...
Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Gen...
Inflammatory Bowel Diseases or IBD affect the gastrointestinal tract and are characterized by recurr...
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is a m...
The human gastrointestinal tract (GIT) is highly colonized by bacterial communities, which live in a...
Background: Mucosal delivery of therapeutic proteins using genetically modified strains of lactic ac...
Background: Mucosal delivery of therapeutic proteins using genetically modified strains of lactic ac...